rxstat › Shortages › Omeprazole

Omeprazole shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Omeprazole products are in shortage in Canada (10 of 22 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 14, 2026.
Products affected
10 / 22
In shortage since
Dec 14, 2018
Est. full return
Aug 14, 2026
Reports on file
88
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
TEVA-OMEPRAZOLE
10MG · TABLET (DELAYED-RELEASE) · TEVA CANADA LIMITED
DIN 02295407 · since Aug 27, 2025, est. end Jul 10, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-OMEPRAZOLE
20MG · TABLET (DELAYED-RELEASE) · TEVA CANADA LIMITED
DIN 02295415 · since Nov 7, 2024, est. end Jun 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-OMEPRAZOLE
20MG · CAPSULE (DELAYED RELEASE) · APOTEX INC
DIN 02245058 · since Jun 16, 2026, est. end Aug 14, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-OMEPRAZOLE
20MG · TABLET (DELAYED-RELEASE) · TEVA CANADA LIMITED
DIN 02295415 · since Dec 3, 2025, est. end Jul 10, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP-OMEPRAZOLE DR
20MG · TABLET (DELAYED-RELEASE) · JAMP PHARMA CORPORATION
DIN 02420198 · since Jan 19, 2024, est. end Jul 24, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP-OMEPRAZOLE DR
20MG · TABLET (DELAYED-RELEASE) · JAMP PHARMA CORPORATION
DIN 02420198 · since Jan 19, 2024, est. end Jul 24, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP-OMEPRAZOLE DR
20MG · TABLET (DELAYED-RELEASE) · JAMP PHARMA CORPORATION
DIN 02420198 · since Jan 19, 2024, est. end Jul 24, 2026 · Disruption of the manufacture of the drug.
Active shortage
NAT-OMEPRAZOLE DR
20MG · TABLET (DELAYED-RELEASE) · NATCO PHARMA (CANADA) INC
DIN 02439549 · since Jun 13, 2024, est. end Jun 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
BIO-OMEPRAZOLE
20MG · TABLET (DELAYED-RELEASE) · BIOMED PHARMA
DIN 02449927 · since Oct 17, 2024, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
OMEPRAZOLE MAGNESIUM DELAYED RELEASE TABLETS
20MG · TABLET (DELAYED-RELEASE) · SANIS HEALTH INC
DIN 02504294 · since ?, no end estimate · Disruption of the manufacture of the drug.
Active shortage
OMEPRAZOLE MAGNESIUM DELAYED RELEASE TABLETS
20MG · TABLET (DELAYED-RELEASE) · ACCORD HEALTHCARE INC
DIN 02416549 · since Apr 12, 2024, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
PMS-OMEPRAZOLE
20MG · CAPSULE (DELAYED RELEASE) · PHARMASCIENCE INC
DIN 02320851 · since Feb 28, 2019, no end estimate · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Omeprazole is currently affected by 10 active shortage reports filed with Health Canada by TEVA CANADA LIMITED, APOTEX INC, JAMP PHARMA CORPORATION, NATCO PHARMA (CANADA) INC and 5 others.

The reported causes are: disruption of the manufacture of the drug; requirements related to complying with good manufacturing practices; other (please describe in comments). Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Omeprazole is classified under “DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)” (ATC A02BC).

Recent changes

Common questions

When will Omeprazole be back in stock in Canada?

The latest manufacturer estimate is Aug 14, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Omeprazole in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (drugs for peptic ulcer and gastroesophageal reflux disease (gerd))

Widespread shortageFamotidine3 of 13 reported products affected · est. return Sep 18, 2026Partial shortageCimetidine3 of 9 reported products affectedPartial shortageEsomeprazole12 of 26 reported products affected · est. return Oct 10, 2027Partial shortageLansoprazole6 of 22 reported products affected · est. return Dec 29, 2026Partial shortagePantoprazole7 of 35 reported products affected · est. return Sep 29, 2026Partial shortageRabeprazole4 of 21 reported products affected · est. return Jun 30, 2026

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.